Results 111 to 120 of about 50,884 (170)

Efficacy, Safety, and Hematologic Recovery Following Intravenous Ferric Carboxymaltose in Patients with Iron Malabsorption-Related Iron Deficiency Anemia: A Prospective Clinical Study. [PDF]

Nutrients
Scalamonti S, Pivetta G, Schiavone FP, Magnante M, Pompili M, Vavallo M, Annibale B, Lahner E.   +7 more
europepmc   +1 more source

Fetal Safety of Intravenous Ferric Carboxymaltose in Pregnancy: A Cardiotocography Study from a Tertiary Care Hospital in Italy. [PDF]

Hematol Rep
Polese F, Pesce C, De Fusco G, Tidore G, Coluccia E, Battista R, Gessoni G.   +6 more
europepmc   +1 more source

Evaluation of Safety and Efficacy of Ferric Carboxymaltose for the Treatment of Iron Deficiency Anaemia in Pregnancy and Postpartum: A Retrospective Observational Study. [PDF]

Cureus
Yadav P, Kamboj S, Sharma KA, Rana A, Malhotra N.   +4 more
europepmc   +1 more source

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure. [PDF]

Sci Rep
Mollar A, García-Conejo C, Revuelta-López E, Cardells I, López R, Del Canto I, de la Espriella R, Lopez-Lereu MP, Monmeneu JV, Maceira A, Lakhal-Littleton S, Almenar L, Cases A, Peiró M, Bayés-Genís A, Núñez J.   +15 more
europepmc   +1 more source

Prolonged and Refractory Hypophosphataemia Following Intravenous Ferric Carboxymaltose Administration Delaying Hospital Discharge: A Case Report. [PDF]

Cureus
Sajid Z.
europepmc   +1 more source

The use of parenteral application of ferric carboxymaltose in the prevention of iron deficiency anaemia in suckling piglets. [PDF]

Vet Med (Praha)
Svoboda M, Vasek J, Jarkovsky J, Skupien V, Vitkova V.   +4 more
europepmc   +1 more source

Ferric carboxymaltose increases fracture risk in patients and reduces bone formation in mice with iron deficiency anemia.

Blood
Wagner SA, Panzer M, Pertler E, Redl S, Saretto M, Schaefer B, Pammer LM, Obholzer L, Troppmair MR, Hess MW, Salvenmoser W, Degenhart G, Grossgut M, Talasz H, Faserl K, Sarg B, Haubner R, Hartmann MA, Blouin S, Petzer V, Gronich-Wondrak P, Kronbichler A, Manzl C, Glodny B, Tilg H, Franke A, Wolf M, Hadjihannas MV, Zoller H.   +28 more
europepmc   +1 more source

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity. [PDF]

Ren Fail
Cases A, Puchades MJ, Casas-Todoli J, Nuñez J, Peña CJ, Gorriz JL.   +5 more
europepmc   +1 more source

Intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anaemia in pregnancy in Nigeria: a cost-utility analysis.

Lancet Obstet Gynaecol Womens Health
Akinajo OR, Annerstedt KS, Santos MT, Afolabi BB, Banke-Thomas A.   +4 more
europepmc   +1 more source

Integrating a single-dose intravenous iron therapy (ferric carboxymaltose) for maternal anaemia in Nigeria: Insights from stakeholder engagement. [PDF]

J Public Health Afr
Thompson RA, Gwacham-Anisiobi U, Obi-Jeff C, Balogun M, Akinajo OR, Oluwole E, Adelabu Y, Audu T, Afolabi BB, Banke-Thomas A.   +9 more
europepmc   +1 more source